Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
For example: In a 2010 trial at New York's Memorial Sloan Kettering Cancer Center, more than 90% of bladder-cancer patients failed to respond to the ...
Cannabis use is inversely associated with incidences of bladder cancer in males, according epidemiological findings published in the February issue ...
Roche's (RHHBY - Analyst Report) subsidiary, Genentech, announced that the FDA has granted Breakthrough Therapy designation to its ...
Researchers in the German-speaking world are honing in on tantalizing cancer therapies. The problem? Those which leverage the immune system ...
The Melanoma Institute Australia hopes the immunotherapy drug — from ... drugs help the immune system detect and attack the hidden cancer cells.
“We've found that these cells are much more effective at [fighting] cancer and [maintaining] long-term cancer regression” in mice than central and ...
Pancreatic cancer cells are notorious for being protected by a fortress of tissue, making it difficult to deliver drugs to either shrink the tumor or stop its ...
News & Observer
It represents a fundamentally new treatment approach for pancreatic cancer, which has a 75 percent mortality rate within a year of diagnosis - a ...
First it targeted pancreatic cancer. Now it's moved onto oral cancer. A new study from Penn State University shows the main antioxidant in green tea, ...
FDA Approves Palbociclib for Advanced Breast Cancer
The FDA has approved the CDK4/6 inhibitor palbociclib (Ibrance) for the treatment of postmenopausal women with metastatic breast cancer.
The FDA has approved the CDK4/6 inhibitor palbociclib (Ibrance) for the treatment of postmenopausal women with metastatic breast cancer.
New Biopsy Method Ups Detection of High-Risk Prostate Cancer
A targeted magnetic resonance/ultrasound fusion-guided biopsy technique produced better results than a standard biopsy for detecting high-risk prostate cancer.
A targeted magnetic resonance/ultrasound fusion-guided biopsy technique produced better results than a standard biopsy for detecting high-risk prostate cancer.
Tarextumab Gets FDA Orphan Drug Designation for Lung, Pancreatic Cancer
The US Food and Drug Administration has granted orphan drug designation to tarextumab for the treatment of pancreatic cancer and small-cell lung cancer.
The US Food and Drug Administration has granted orphan drug designation to tarextumab for the treatment of pancreatic cancer and small-cell lung cancer.
Urine Test Detects Bladder Cancer Recurrence
A urine test (CellDetect) was able to detect disease recurrence in bladder cancer patients, with a reported sensitivity of 84.4% and specificity of 82.7%.
A urine test (CellDetect) was able to detect disease recurrence in bladder cancer patients, with a reported sensitivity of 84.4% and specificity of 82.7%.
Frailty Score Predicts Survival in Elderly Myeloma Patients
A scoring system that measured frailty in elderly patients with multiple myeloma was able to accurately predict mortality and risk of toxicity.
A scoring system that measured frailty in elderly patients with multiple myeloma was able to accurately predict mortality and risk of toxicity.
Surveillance Yields Excellent Long-Term Outcomes in Stage I Testicular Cancer
Active surveillance is effective and yields good outcomes in patients with clinical stage I testicular cancer who underwent orchiectomy.
Active surveillance is effective and yields good outcomes in patients with clinical stage I testicular cancer who underwent orchiectomy.
Breast Cancer Patients Often Don't Know Details of Their Tumor
Many women with breast cancer do not understand the details of their tumor characteristics or how they relate to specific treatment options, according to a new study.
Many women with breast cancer do not understand the details of their tumor characteristics or how they relate to specific treatment options, according to a new study.
Science Daily Cancer News
A team of researchers has devised a new way to target tumors with cancer-fighting drugs, a discovery that may lead to clinical treatments for cancer patients. Called iontophoresis, the technique delivers chemotherapy to select areas.
A protein newly found in the naked mole rat may help explain its unique ability to ward off cancer. The protein is associated with a locus that is also found in humans and mice. It's the job of that locus to encode several cancer-fighting proteins. The locus found in naked mole rats encodes a total of four cancer-fighting proteins, while the human and mouse version encodes only three.
A novel Electron Paramagnetic Resonance (EPR) oximetry technique will help clinicians directly measure oxygen and schedule treatments at times of high oxygen levels in cancer and stroke patients to improve outcomes, researchers have found.
In recent years, medical professionals have been greatly interested in the development of new treatments to combat the spread of cancer, which is the largest cause of death in patients with this illness. A new study details how cells with low levels of the profilin 1 protein in breast tumors increase their capacity to metastasize and invade other tissues.
Nanoparticles have been used to successfully deliver a new therapy to cancer cells in the brains of rats, prolonging their lives, scientists report. Previous research on mice found that nanoparticles carrying genes can be taken up by brain cancer cells, and the genes can then be turned on. However, this is the first time these biodegradable nanoparticles have effectively killed brain cancer cells and extended survival in animals.
Head and neck squamous cell cancer (HNSCC) ranks among the top ten most prevalent cancers in the United States. Despite its prevalence, little is known about how this cancer develops and spreads. However, researchers now offer critical new information about head and neck cancers.
A new study finds alterations in expression of genes PIK3R3 and PTEN, more commonly observed in adult tumors, in the rare, young-adult bone cancer Ewing Sarcoma, potentially offering ways to improve therapy.
A new study identifies three genes that together enable a lethal form of brain cancer to recur and progress after radiation therapy. The findings could lead to new therapies for brain tumors that target cancer stem cells.
A physician is leading a study for women with a higher risk of breast cancer that focuses on two natural approaches to preventing breast cancer: weight loss and omega-3 fatty acids EPA and DHA.
Tambahkan Komentar